Li-Man Liu, Li-Ping Zhao, Ling-Jie Wu, Luo Guo, Wen-Yan Li, Yan Chen
{"title":"Characterization of the transcriptomes of <i>Atoh1</i>-induced hair cells in the mouse cochlea.","authors":"Li-Man Liu, Li-Ping Zhao, Ling-Jie Wu, Luo Guo, Wen-Yan Li, Yan Chen","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Postnatal mammalian cochlear hair cells (HCs) can be regenerated by direct transdifferentiation or by mitotic regeneration from supporting cells through many pathways, including Atoh1, Wnt, Hedgehog and Notch signaling. However, most new HCs are immature HCs. In this study we used RNA-Seq analysis to compare the differences between the transcriptomes of <i>Atoh1</i> overexpression-induced new HCs and the native HCs, and to define the factors that might help to promote the maturation of new HCs. As expected, we found <i>Atoh1</i>-induced new HCs had obvious HC characteristics as demonstrated by the expression of HC markers such as <i>Pou4f3</i> and Myosin VIIA (Myo7a). However, <i>Atoh1</i>-induced new HCs had significantly lower expression of genes that are related to HC function such as Slc26a5 (<i>Prestin</i>), <i>Slc17a8</i> and <i>Otof</i>. We found that genes related to HC cell differentiation and maturation (<i>Kcnma1</i>, <i>Myo6</i>, <i>Myo7a</i>, <i>Grxcr1</i>, <i>Gfi1</i>, <i>Wnt5a</i>, <i>Fgfr1</i>, <i>Gfi1</i>, <i>Fgf8</i> etc.) had significantly lower expression levels in new HCs compared to native HCs. In conclusion, we found a set of genes that might regulate the differentiation and maturation of new HCs, and these genes might serve as potential new therapeutic targets for functional HC regeneration and hearing recovery.</p>","PeriodicalId":7657,"journal":{"name":"American journal of stem cells","volume":"9 1","pages":"1-15"},"PeriodicalIF":1.5000,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076321/pdf/ajsc0009-0001.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of stem cells","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Postnatal mammalian cochlear hair cells (HCs) can be regenerated by direct transdifferentiation or by mitotic regeneration from supporting cells through many pathways, including Atoh1, Wnt, Hedgehog and Notch signaling. However, most new HCs are immature HCs. In this study we used RNA-Seq analysis to compare the differences between the transcriptomes of Atoh1 overexpression-induced new HCs and the native HCs, and to define the factors that might help to promote the maturation of new HCs. As expected, we found Atoh1-induced new HCs had obvious HC characteristics as demonstrated by the expression of HC markers such as Pou4f3 and Myosin VIIA (Myo7a). However, Atoh1-induced new HCs had significantly lower expression of genes that are related to HC function such as Slc26a5 (Prestin), Slc17a8 and Otof. We found that genes related to HC cell differentiation and maturation (Kcnma1, Myo6, Myo7a, Grxcr1, Gfi1, Wnt5a, Fgfr1, Gfi1, Fgf8 etc.) had significantly lower expression levels in new HCs compared to native HCs. In conclusion, we found a set of genes that might regulate the differentiation and maturation of new HCs, and these genes might serve as potential new therapeutic targets for functional HC regeneration and hearing recovery.
哺乳动物出生后耳蜗毛细胞(HCs)可通过Atoh1、Wnt、Hedgehog和Notch信号通路等多种途径从支持细胞直接转分化或有丝分裂再生。然而,大多数新的hcc是不成熟的hcc。在本研究中,我们使用RNA-Seq分析比较了Atoh1过表达诱导的新hcc与天然hcc的转录组差异,并确定了可能有助于促进新hcc成熟的因素。正如预期的那样,我们发现atoh1诱导的新HC具有明显的HC特征,如HC标记物Pou4f3和Myosin VIIA (Myo7a)的表达。然而,atoh1诱导的新HC显著降低了与HC功能相关的基因如Slc26a5 (Prestin)、Slc17a8和Otof的表达。我们发现,与HC细胞分化和成熟相关的基因(Kcnma1、Myo6、Myo7a、Grxcr1、Gfi1、Wnt5a、Fgfr1、Gfi1、Fgf8等)在新hcc中的表达水平明显低于天然hcc。总之,我们发现了一组可能调控新HC分化和成熟的基因,这些基因可能成为功能性HC再生和听力恢复的潜在新治疗靶点。